Skip to content
Clarrio.ai

Platform Terms & Conditions

KnowRisk Web App · Version of February 23rd 2025

Introduction

Welcome to Clarrio.ai! These Terms and Conditions ("Terms") govern your use of the KnowRisk Web Application ("Platform"), provided by Clarrio.ai, operated by KNOWLEPSY INVESTMENT SAS ("Company"). By downloading, accessing, or using the Platform, you agree to be bound by these Terms. If you do not agree with these Terms, do not use the Platform.

Definitions

• The Mobile App: The KnowRisk Mobile Application accessible via Apple Store and Google Store for patients data collection

• User: Any licensed health care professional or entity accessing or using the Platform.

• Payer: The entity (hospital, clinic, or pharmaceutical company) that purchases licenses for the Platform and acts as the data controller.

• Solution Provider: Clarrio.ai.

• Patients: Individuals using the KnowRisk Mobile Application and whose data is accessible by the Payer and the User following their explicit consent.

Use of the Platform

• Purpose: Access patients' real-time and historical physical, environmental and behavioral data and analytics for better healthcare monitoring and decision making.

• Eligibility: You must be a licensed medical professional with a permit that allows you to practice medicine in the state/country in which the data is collected. By using the Platform, you represent and warrant that you meet this requirement.

• Platform License Grant: We grant you a limited, non-exclusive, non-transferable, revocable license to use the Platform for your professional use only and limited to the Terms of the payer.

• User Account: You may be required to create an account to access certain features of the Platform. You are responsible for maintaining the confidentiality of your account information and for all activities under your account.

License and Access

• The Payer purchases a specified number of licenses for their authorized Users.

• Access to the Platform is granted to Users as determined by the Payer.

• Users must use the Platform in accordance with these Terms and any applicable laws and regulations of their country.

The Payer Responsibilities

• The Payer is the Data Controller and is responsible for determining the purposes of processing patients' data.

• The Payer ensures compliance with data protection laws, including GDPR and HIPAA, and controls access to the Platform for their authorized Users.

• The Payer must ensure that all Users are trained on data protection and privacy requirements.

• The Payer must ensure that all Users are licensed medical professionals with an up to date permit that allows them to practice medicine in the state/country in which the data is collected.

User Responsibilities

• Users must use the Platform solely for lawful purposes and in accordance with these Terms.

• Users must maintain the confidentiality of their login credentials and promptly notify the Payer of any unauthorized access or security breaches.

• Users must maintain the confidentiality of their patients' data.

• Users must comply with all applicable data protection and privacy laws.

Solution Provider Responsibilities

• Clarrio.ai acts as the Data Processor and processes patients' data on behalf of the Data Controller (Payer).

• Clarrio.ai implements appropriate technical and organizational measures to ensure the security and confidentiality of personal data.

Privacy and Data Access & Use

• Personal Data: We collect and process patients' data in accordance with our Privacy Policy. Please review our Privacy Policy to understand our practices.

• Data Collection and Use: We may collect sensitive data-driven insights. We handle this data with enhanced care and confidentiality.

• Access to patient health data is restricted to authorized Users as determined by the Payer.

• Clarrio.ai employs role-based access control and other security measures to protect patient data.

• Regular audits and compliance reviews are conducted to ensure data security and privacy.

• Consent: By using the Platform, you consent to our Privacy Policy and these Terms.

Medical Disclaimer

• No Medical Advice: The Platform provides data-driven insights but does not offer personalized health insights. Medical advice and decisions remain the sole responsibility of the health professionals.

• Not for Emergency Use: The Platform and Mobile App are not intended for emergency situations.

Intellectual Property Rights

• Ownership: The App and its contents, including all intellectual property rights therein, are owned by KNOWLEPSY INVESTMENT SAS.

• Restrictions: You may not use, copy, modify, or distribute the Platform or its content without our express permission.

Payment and Maintenance of Access

• The Payer is responsible for ensuring timely payment of all fees associated with the licenses purchased.

• Failure to make timely payments may result in suspension or termination of access to the Platform for all authorized Users.

• The Payer must maintain an active subscription to ensure uninterrupted access to the Platform.

Limitation of Liability

• Disclaimer of Warranties: The Platform is provided "as is" without any warranties of any kind, either express or implied.

• Limitation of Liability: To the fullest extent permitted by law, KNOWLEPSY INVESTMENT SAS shall not be liable for any indirect, incidental, special, consequential, or punitive damages arising out of or related to your use of the Platform.

Changes to Terms

We reserve the right to modify these Terms at any time. Your continued use of the App following any changes indicates your acceptance of the new Terms.

Governing Law

These Terms are governed by the laws of the Payer's country of registration without regard to its conflict of law principles.

Contact Information

If you have any questions about these Terms, please contact us at contact@clarrio.ai.

Data Consent and Privacy

For information regarding data privacy, please refer to our Data Privacy Policy available on the website or contact us at privacy@clarrio.ai.

Document versionTerms & Conditions KnowRisk Web App V1
Date of validationFebruary 23rd 2025
Drafted byRihab Hafidhi (PMO)
Validated byFiras Rhaiem (CEO), Rim Jaziri (Legal Advisor)